Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of basophil activation in patients with aspirin-exacerbated respiratory disease.
Mitsui C, Kajiwara K, Ono E, Watai K, Hayashi H, Kamide Y, Fukutomi Y, Sekiya K, Tsuburai T, Yamamoto K, Taniguchi M. Mitsui C, et al. Among authors: hayashi h. J Allergy Clin Immunol. 2017 Oct;140(4):1162-1164.e8. doi: 10.1016/j.jaci.2017.03.036. Epub 2017 Apr 25. J Allergy Clin Immunol. 2017. PMID: 28454740 No abstract available.
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
Taniguchi M, Mitsui C, Hayashi H, Ono E, Kajiwara K, Mita H, Watai K, Kamide Y, Fukutomi Y, Sekiya K, Higashi N. Taniguchi M, et al. Among authors: hayashi h. Allergol Int. 2019 Jul;68(3):289-295. doi: 10.1016/j.alit.2019.05.001. Epub 2019 Jun 21. Allergol Int. 2019. PMID: 31235242 Free article. Review.
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Kamide Y, Nakamura Y, Hamada Y, Tomita Y, Sekiya K, Tsuburai T, Izuhara K, Wakahara K, Hashimoto N, Hasegawa Y, Taniguchi M. Hayashi H, et al. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1488-1498. doi: 10.1164/rccm.201906-1215OC. Am J Respir Crit Care Med. 2020. PMID: 32142372 Free PMC article. Clinical Trial.
Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease.
Hayashi H, Mitsui C, Nakatani E, Fukutomi Y, Kajiwara K, Watai K, Sekiya K, Tsuburai T, Akiyama K, Hasegawa Y, Taniguchi M. Hayashi H, et al. J Allergy Clin Immunol. 2016 May;137(5):1585-1587.e4. doi: 10.1016/j.jaci.2015.09.034. Epub 2015 Nov 11. J Allergy Clin Immunol. 2016. PMID: 26559322 Clinical Trial. No abstract available.
6,578 results